Further laboratory diagnosis should be undertaken to verify the molecular mechanism underlying the relationship between B3GNT6 levels and KRAS mutation, CIN, and increased proteasomal activity. This evidence concerns the gene KRAS and cervical squamous intraepithelial neoplasia.